http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106432201-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
filingDate 2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106432201-B
titleOfInvention A kind of preparation method of candesartan cilexetil crystal
abstract The invention belongs to the technical field of crystallization, and particularly relates to a crystallization preparation method of candesartan medoxomil. The technical scheme of the present invention is as follows: in the first step, candesartan cilexetil is added to the alcohol aqueous solution, the solid-liquid ratio of the solution is 0.01g/g~0.1g/g, and the solution is continuously stirred and dissolved for 30~60 minutes at 25~45°C The second step filtration, the filtrate is moved into the crystallizer and kept at 25~45 ℃, and the water of 1~3 times of the water in the initial solution is added to the crystallizer, and the flow rate is 0.5~2g/min; Add seeds to the crystallizer, and grow the crystals for 1 to 2 hours; then add water 10 to 20 times the amount of water in the initial solution into the crystallizer, with a flow rate of 0.5 to 5 g/min, and grow the crystals for 2 to 4 hours; the third step filter. The invention provides a preparation method of candesartan medoxomil crystal form I with controllable particle size.
priorityDate 2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456475560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 32.